B cell responses to a peptide epitope. II: Multiple levels of selection during maturation of primary responses by Tuteja, Renu et al.
Immunology and Cell Biology (1997) 75, 245-252
B cell responses to a peptide epitope. II: Multiple levels of
selection during maturation of primary responses
RENU TUTEJA,' ANSHU AGARWAL,' LALITHA VIJAYAKRISHNAN,' BISHNU P
NAYAKJ SATISH K GUPTA,' VIJAY KUMAR- AND KANURY VS
Ummunology and '^Virology Groups. International Center for Genetic Engineering and Biotechnology and
^National Institute of Immunology. Aruna Asaf Ali Marg. New Delhi. India
Summary This report analyses murine primary humoral recognition of a linear domain (MEP 17-31) within
a 100 amino acid polypeptide. MEP-I. An analysis of the early primary IgM response revealed that MEP
17-31 presented at least two distinct domains for pre-immune B cell recognition represented by MEP-1
residues 19-23 and 26-28. However, subsequent maturation into an IgG response saw an exclusive selection
for the anti-MEP 19-23 component with loss of all alternate specificities. The IgM response to MEP 19-23
was oligoclonal and composed of diverse paratope phenotypes as evidenced by varied heavy chains of
immunoglobulin V—D-J combinations and CDR3 sequences. In contrast to the oligoclonality of IgM niAb. the
mature IgG response to MEP 19-23 appeared to derive predominantly from a single progenitor. It therefore
appears that maturation of primary humoral responses to polypeptide antigens involves two distinct levels of
selection. While there is selection for a restricted subset of the initially induced antibody Hne-specificities,
progression of the response also entails a reduction in clonal heterogeneity of B cells responding to the domi-
nant epitope.
Key words: clonal selection, peptide epitope. primar>' response.
Introduction
The combined realization that B cells generally recognize
protein antigens in their native form and that the pre-immune
B cell repertoire represents a virtually limitless library of pre-
formed sig specificities has led to the dogma that the entire
accessible surface of a protein represents an antigenic con-
tinuum.' Although perhaps correct in principle, it, however,
contrasts in practice with several studies documenting segre-
gated B cell recognition.-"^ A notable example of this is that
of hen egg white lysozyme where the murine primary
humoral response is entirely dominated by antibodies specif-
ic to the amino terminus of the molecule.- Selective murine
humoral recognition of epitopes was also observed in our
studies with a recombinant, designed polypeptide MEP-l.*"-^
A further exploration of this phenomenon revealed that at
least part of the explanation resides in the epitopic bias which
accrues during maturation of the primary response.^
Collectively the data described above suggest that
immunogenicity of antigenic determinants presented by a
polypeptide antigen is not necessarily a correlate of its acces-
sibility for B cell recognition. Indeed these and some of our
more recent results implicate the operation of immunological
mechanisms that eventually select for only a restricted subset
of B cell specificities, leading to hierarchical immunodomi-
nance.'** It therefore appears that the induction and matur-
ation of antibody responses to polypeptide immunogens
involves a far greater degree of complexity than that against
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haptens. the currently employed models for studying such
phenomena.^
An empirical approach was adopted in a preliminary study
in which we examined generation and subsequent maturation
of murine antibody responses to a linear segment, as a model
antigenic determinant, of 1(X) amino acid residue recombin-
ant, designed polypeptide. MEP-1.^ The linear segment repre-
sents amino acid residues at positions 17-31 of MEP-1 and
has been previously shown to constitute an miniunodomtnant
epitope of this antigen in the murine model.'^ •^ A single
immunization of mice with MEP-1 was found to generate an
early primary IgM polyclonal response that included varied
antibody specificities collectively recognizing a major pro-
portion of the 17-31 amino acid sequence, interestingly, dis-
section of this response into individual mAb specificities
revealed that at least two distinct subsegments between posi-
tions 19-23 and 26-28 were independently recognized,
although a bias in favour of the 19-23 sequence was noted.
Subsequent maturation into a late primary IgG response was
exclusively directed against the MEP 20-23 segment with
loss of all alternate specificities. We also examined the clo-
nal heterogeneity of anti-MEP 19-23-responder B cells in the
early primary IgM and late primary IgG responses. While the
IgM response was composed of antibodies collectively using
a diverse array of V^^ , D^^ and Jj, gene combinations, the late
primary IgG response consisted of B cells expressing anti-
body molecules using identical V^, D^ and J^ gene segments
with identical V,,-D,| and D^^-}y^ joinings along with a com-
mon K light chain. It therefore appears that primary antibody
responses to polypeplide determinants involves at least two
distinct levels of selection, one for specificity and another
that restricts clonal diversity of B cells initially induced
against a common epitope.
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Materials and methods
Materials
Horseradish pcroxidase (HRPO) abelled goat anti-mouse IgG
(Y-specitic) and IgM ()i-specific) were purchased from Sigma Chemi-
cal Company (Si Louis, MO. USA). tBoc-protected amino acids for
peptide synthesis were obtained from Nova Biochem (Laufelfingen,
Swiizerlandt. For inultipin synthesis of peplides, both the non-cleav-
able kits and Fmoc iimino acid derivatives were purchased from
Chiron Mimoiopes Inc. (Claylnn. Vie,. Australia!.
The polypepi ide MEP-1 was obtamed as the expressed product of a
synthetic gene in Eschenchia coli. Its expression and purification,
followed by disullide rearrangements and eharacterization have been
described in detail elsewhere.'"
Peptide synthesis
Tlie peptide MEP 17-31 was synthesized by the solid phase method
on an ABI model 430A automated peplide synthesizer (Applied
Biosystems. Foster City, CA. USA)." After synthesis, side-ehain
deproteciion and cleavage from the resin was achieved with a 10%
solution of trifluoromethanesulfonic acid in trifluoroacetic acid as
previously described.'- All peptides were purified lo at least 95%
purity by reverse phase HPLC on a C-18 column (|i Bondapak,
7.8 mm X 30 cm; Waters, Milford, MA, USA) using an aqueous
gradient of D-60% acetonitrile in 0.1% irifluoroacetic acid. Identity of
ail pepttdes was ascertained by amino acid analysis.
All hexapeptides were synthesized by the method of Geysen using
the non-cleavable mullipm kils.'^ For synthesis the standard protocol
recommended by the manufacturer was employed. After completion
of synthesis, peptides were routinely acetylated at the amino terminus
with a 50 : 5 ; I mixture of dimethylformamide, acetic anhydride and
triethylamine. Side chain deprotection was accomplished over 2 h al
room temperature with a 38 : 1 : I (v/v/v) mixture of trifluoroacetic
acid, ethanedithiol and anisole.
Animals and immunization
Female mice (6-8 weeks old) were obtained from the small animal
breeding facility at the National Institute of Immunology, New Delhi,
India. Immunizations were i.p. with a dose of 20 (ig MEP-1 per mouse
(100 [iL) as an emulsion in CFA. For polyclonal sera, mice were bled
from the retro-orbital plexus and sera within a group pooled.
Generation of monoctonal antibodies
For early primary IgM mAb, a group of ihree female BALB/c mice
were immunized with MEP-1 as described above. Four days later
mice were bled individually and sera was checked for anti-MEP-1
antibody titres. The mouse with the highest titre (I : 500) was chosen
for hybridoma production. The spleen was removed surgically and
cells fused to give early stage primary hybridomas. Polyelhylene gly-
col-mediated fusion to hypoxanthine-;\minopterin-thymidine-sensitive
myeloma derivative SP2/0-Ag 14, maintenance of derived lines and
limiting dilution cloning was es.sentially as previously described.'"'
Culture supernatants were screened for IgM antibody production
against an MEP 17-31 synthetic peptide by ELISA. Nine anti-MEP
[7_31.secreting IgM clones were initially obtained, though the
hybridoma 608 subsequently lost the ability to secrete antibody on
continuous culture. '
For the mature IgG mAb, mice immunized with MEP-! were boost-
ed on day 28 intravenously with 20 (ig of soluble antigen in PBS.
Three days later the spleen from the highest responder mouse was
removed and hybridomas obtained as described above. The dissoci-
ation constant of individual mAb for MEP-l was determined using the
solution phase saturation ELISA protocol of Friguet et a!.^^ Culture
supernatants were used with final antibody concentrations between
100 and 200 ng/mL.
EUSA assays for soiubie antigen
Plates were coated at 2 i^g of MEP 17-31 peptide or 200 ng of MEP-1
per well in 100 |iL of PBS (pH 7.4) at 37°C for 3.5 h. They were then
blocked with 300 |iL/well of a 5% solution of fat-free dry milk pow-
der in PBS at 37-C for 1 h and 1(X) ^ iL of the appropnate dilution (or
concentration) of mouse antiserum (or mAb) was added and plates
were incubated at 37'^ C for I h. After washing, bound antibody was
detected with HRPO-labelled secondary antibody (37°C, I h)
followed by colour development with o-phenylenediamine as chro-
mogen. Absorbance was measured at 490 nm.
For competitive ELISA experiments, 5 |iL of PBS containing the
appropriate amounts of competitor peptide was added to 250 i^L of
mAb diluted to 50% of its titre. These were then incubated for 10 min
at room temperature prior to the addition to duplicate wells (100
)iL/welI). The rest of the procedure was as described above.
ELISA assays for pin-bound hexapeptides
Hexapeptide sets synthesized on pins were also evaluated for antibody
cross-reactivity by ELISA. The protocol recommended by the manu-
facturer was strictly followed. Primary antibodies were diluted to
appropriate concentrations m PBS containing 1% BSA, 0.1% (v/v)
Tween 20 and 0.1% (w/v) sodium azide. Pins were incubated in
200 |iL each of the antibody solution at 4°C overnight with genlle
shaking. Pins were then washed and subjected to a second round of
HRPO-labelled goat anti-mouse IgM or IgG at room temperature for
1 b with gentle shaking. The chromogen used for revealing bound
antibody was 2,2"-azino-bis (3-ethylbenzthiazoline'6-sulfonic acid)
diammonium (ABTS) and absorbance was measured at 405 nm with
subtraction of that at 490 nm.
Reverse transcription and amplification of Ig mRNA
Total cellular RNA was isolated from about 10' hybridoma cells with
the R NAzol B (Wak-chemie Medical. GMBH, Gernianyj-based pro-
tocol with minor modifications. About 10 )ig of total RNA was used
for each V' gene cDNA amplification. The first strand of cDNA was
synthesized using 20 U of reverse transcriptase (Promega, Madison,
WI. USA) and 800 pniol of the primer. 5'-AGACGAGGGGGAA-
GACATTT 3' for C^i. 5'-GGCCAGTGGATAGAC-3' for Cy and
5'-GCTCACTGGATGGTGGGAAGATG-3' for CK in a final volume
of 25 [iL. Single-stranded cDNA was then ainplitied using as
5' primer 5'-AGGT(C/G)(A/C)A(A/G)CTGCAG(G/C)AGTC(AAr)-
GG 3' for V,, and 5'-GA(A/CAr)ATTGTG(A/C)T(G/C)AC(A/C)CA
(A/G){A/T)CTCCA-3' for V^. The primers were synthesized in rhe
laboratory and purified prior to use. A different set of nested 3'
primers were used for amplification. 5'-CATTTGGGAAGGACT-
GACTC-3' for C|l, .')'-GGCCAGTGGATAGAC(T/C/A)GA-3' for Cy
and 5'-GAAGATGGATACAGTTGGTGCA-.V for CK. Amplification
was carried out using 5 |iL of cDNA and Taq polymerase (Slratagene.
La Jolla. CA, USA) in a final volume of i()O|iL. The final concentra-
tions of reagents were 50 mmol/L KCl. 10 mmol/L Tris-HCI (pH 8.8),
1.5 mmol/L MgCI,, 0.01 % gelatin. 200 pmol of each primer and 2.5 U
of Tag polymerase. Polymerase chain reaction (PCR) was performed
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on a Perkin Elmer Ihemiocycler using the following programme of:
one cycle at 95°C for 3 min, followed by 30 cycles at 94°C for 1 min,
58''C for 1.5 min, ll'-'C for 1 min and finally a 10 min incubation at
72°C. A 10 \iL aliquot of the reaction was analysed on a i.%% agarose
gel.
Nucleotide sequencing of polymerase chain reaction
amplified DNA
Polymerase chain reaction products of about 400 b.p. were blunt
ended by polishing with the PCR polishing kit from Stratagene and
subsequently cloned in the Si-f I site of PCR-script vector of the PCR-
script cloning kit from Stratagene. Positive clones were identified by
restriction digestion of plasmid DNA and appropriate clones
sequenced using the T7 sequencing kit purchased from Pharmacia
(Uppsala. Sweden). Both strands of eloned DNA were sequenced. The
immunoglobulin heavy (Igjj) and ''ghl dgL* chain variable region
gene sequences were analysed using the PC Gene software and the
GenBank data library.
The Ig|^  nucleotide sequence data reported in this paper appears in
the EMBL. GenBank and DDJB Nucleotide Sequence Databases
under the following accession numbers: mAb 603. Z61S168; mAb 604.
Z68169: mAb 605, Z68170; mAb 609. Z6817I: mAb 611. Z68172:
mAb 612. Z6X173; mAb fi23. Z6S174: mAh 624. Z6S175: mAh 626.
Z68176; mAb 628. Z68177; mAb 627. Z68178.
Results
Primary polyclonal responses to an immunodominant
domain of MEP-I
Figure 1 gives the amino acid sequence of the polypeptide
MEP-1 where the immunodominant epitope of MEP-1.
residues 17-31. is highlighted. Following immunization of
BALB/c mice with MEP-1. IgM class antibodies against a
synthetic peptide representing the MEP 17-31 sequence
could be detected as early as day 3, whereas IgG became
evident by day 7. though, predictably, titres were low
(< 1 : 250). With time, there was a rapid accumulation of
anti-MEP 17-31 IgG and titres peaked at 1 : 30.000 by day
28 (data not shown).
A panel of overlapping hexapeptide sequences that repre-
sented single amino acid displacements over the MEP 17-31
sequence was used to probe for distribution of antibody tine
specificities and results are shown in Fig. 2. Day 3 antiscrum
(IgM) was found to cross-react with a spectrum of overlap-
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Figure 1 Amino acid sequence of the polypeptide MEP-1. MEP-1
represents a polyvalent polypeptide that contains various segments
derived from the envelope proteins of hepatitis B virus. Details of
epitopes selected, design of polypeptide. assembly of the gene and its
expression in Eschcrichia coii has been previously desenbed.'" T^e
single letter code for amino acids is used and the immunodominant
domain spanning residues 17-31 has been boxed.
MEP-1
Residue
17-22
lfl-23
19-2t
20-25
21 -26
22-27
23-18
2*-29
25-30
26-31
Sequence
HOLDPA
OLDPAF
LD PAF6
DPAFGA
PAFGAN
AF&AN5
F&ANST
GANSTA
ANSTAN
N S T A N P
o — — •>•
• •• r I 1 1 1
A — B
I
.
I
.
.
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Figure 2 Localization of early and late primary polyclonal anti-
MEP-1 bmding sites within Ihe MEP 17-31 sequence. Pins contain-
ing the MEP 17-31 derived overlapping hexapeptides were incubat-
ed in 200 |iL each of either (A) a I : 10(1 dilution of day 3 anii-MEP-l
and bound IgM; or (B) a 1 : 6000 dilution of day 2X anti-MEP-l and
bound IgG. Values are expressed as the absorbance obiained for a
given peptide after subtraction of that obtained for a negative conlrni
peplide of sequence AQGNSM that was synthesized in triplicate.
The mean absorbance obtained for negative control peptide was 0.15
units with day 3 serum and 0-05 absorbance units with day 28 serum.
Data are representative of three separate experiments.
ping hexapeptides collectively spanning MEP-1 residues
17-28 (Pig. 2a). In contrast, however, recognition by day 28
serum (IgG) was restricted to three overlapping peptides
cotlectively representing MEP-1 residues 18-2-*t (Fig. 2b):
suggesting that the dominant antibody specificity in this pop-
ulation is directed against a tetrapeptide stretch of MEP-1
residues 20-23 {sequence, DPAF).
Thus it would appear that, although early primary IgM
recognition of the MEP 17-31 domain, in the context of
MEP-1. encompasses a major proportion of the sequence,
specificity of the mature primary polyclonal response is, how-
ever, far more restricted. In separate studies essentially simi-
lar results were obtained in three additional strains o'i mice
C3H/HeJ, SJL/J and C57BI/6 (data not shown); suggesting
that the observations in Fig. 2 is not unique to a given murine
H-2 haplotype.
Antibody repertoire in the MEP 17-31 -specific I}>M
response
The early primary IgM response directed against the MEP
17-31 sequence appeared to be composed of multiple
specificities. To verify this MEP 17-31-specific mAb were
generated from a BALB/c mouse that had been immunized 4
days earlier with MEP-I. Selection of hybrids was specific
for IgM-secreting clones to enable us to examine antibodies
which represent specificities directly derived from the pre-
immune B cell pool and prior to the onset of maturation
events within.'' A total of nine independently derived clones
were obtained of which one (mAb 608) subsequently turned
non-secretor on continuous culture. As a result only limited
analysis could be performed with this antibody.
In addition, two independent fusions were also peiformed
with spleens from non-immune BALB/c mice. While a total
of 82 clones were obtained from the first fusion, the .second
yielded 66. Culture supematanis from all of these clones were
screened for cross-reactivity against the MEP 17-31 peptide.
Only a single clone from each of these sets was found to
produce antibodies that cross-reacted with MEP 17-31; sug-
gesting that at least a majority of the MEP 17-31 specific
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hybridonias obtained above were derived from antigen-
ucliviited B celts. Ftirther, binding of al! the nine mAb to
solid-bound MEP-l could be inhibited to greater than 90% by
a 10-fold molar excess of soluble MEP 17-31 peptide in a
cotnpetitive ELISA assay (data not shown). We infer from
this that, for all these mAb. binding specificities are entirely
localized to determinants within the linear 17-31 sequence of
MEP-l.
To examine the genetic repertoire of an anti-MEP 17-31
IgM response we determined the nucleotide sequence of the
heavy chain variable regions of mAb which are shown in
Fig. 3. Except for mAb 612. 613 and 614 which gave identi-
cal sequence, the remaining mAb were found to derive from
Table 1 Clonal heterogeneity of the early primary IgM response to
MEP 17-31
distinct B cells. Diverse utilization of V and /// gene
combinations was evident with no apparent restriction in
either length or sequence of the CDR3 region. A summary of
the anti-MEP 17-31 IgM is presented in Table I. Although
four of six distinct mAb utilized V^ genes from the J558 fam-
ily {Table 1), they all represented separate members (Fig. 3).
The data in Fig. 3 and Table I would seem to indicate that the
anti-MEP 17-31 IgM response is composed of phenotypical-
ly {and presumably also structurally) distinct paratopes.
Monoclonal
antibody
603
604
605
608
609
611
612-614
Light chain
isotype
K
K
K
K
K
K
K
Heavy chain
VH
Q52
J558
J558
ND
J558
7183
J558
DH
Q52
FL16.2
SP2.2
ND
Q52-C
SP2.5
JH
3
1
4
ND
4
2
2
CDR3 sequence
(amino acid)
NAY
IPITTATNWYDFV
STMITTVYAMDY
—
SQAMDY
QYGNYKDYFDY
GGVY
This table represents a summar>' of the IgM mAb sequences
depicted in Fig. 3. Light chain isotypes were determined by ELISA
using polyclonal goat anti-mouse K antibodies. V'^  gene families
were identified with the help of the GeneBank database whereas D^
and JH segments were identified by comparison with published
sequences.'^ The D^ gene used by mAb 612-614 could not be
identified by comparison with known murine D gene sequences. ND,
not determined.
603
«04
£05
G09
611
ag gtg cag ctq
ag gtg cag etc
ag gtc sag ctg
aq gtc aag ctg
ag gtc caa ctg
ag gtc aag ctg
ag gag cc
ag gag Cc
ag cag tc
ag cag tc
ag gag tc
ag gag tc
10 20
gga cct ggc cca gtg cag ccc tea cag age etg tee ate ace tgc aca gtc
gga eet gag ctg gtg aag
ggg act gtg ctq gca agg
gga cct gag etg gtg aag
ggg gga ggc tta gtg aag
ggg tet gag ctq gtg agg
ct ggg get cca gtg aag ata tee tge aag act
et ggg get tea gtg aaa atg tec tgc aag get
et ggg get tea gtg aag ata tec tgc aag get
et gga ggg tec etg aaa etc tee tgt gca gee
ct gga get tea gtg aag ctg tec tge aag get
603 tet ggt ttc tea tta aet age tat ggt gta cac tgg gtt cgc cag tet e
604 tet gga tae aca ttc act gaa tac ace atg cac tgg gtg aag cag age e
605 tet gge tae aec ttt ace age tae tgg atg cae tgg gta aaa eag agg c
609 tet ggt tac tea ttt aet gge tac ttt atg aac tgg gtg aag eag age c
611 tet gga ttc aet ttc agt age tat gee ate tet tgg gtt cgc cag aet e
612 tet ggc tae aca ttc ace age tac rgg ar.g eac tgg gtg aag cag agg e
a gga aag ggt ctg gag tgg etg
t gga aag age ctt gag tgg act
t gga eag ggt ctg gaa tgg att
t gga aag age ett gag tgg att
g gag aag agg ctg gag tgg gcc
t gga eaa ggc ctt gag tgg gtt
50 SO "=
603 gga gtg ata tgg - agt ggt gga age aca gac tat aat gea get ttc ata tee aga etg age ate age aag
£04 gga ggt att aat eet aae aat ggt ggt act age tae aae eag aag ttc aaq ggc aag gee aea ttg act qta
€05 gqe get att tat eet gga aat agt gat act age tac aae eag aag ttc aaq qge aag gcc aaa ctg act qc«
609 gqa cgt att aat eet tae aat ggt gat act ttc tae aae eag aag tte aag gqe aag gee aea ttg act qt«
611 gea ace att agt agt ggt ggt agt tac aee tac tat eea gae agt gtg aag ggt ega ttc ace ate tee aga
612 gga AAT arr rah cct gijr ^Qt qff agf Art aae rar ijat qflg aaa tte aaa aac aaq gee aea etg act qt«
603 gae aat tec aag aqe eaa gtt tte ttt aaa atg aae agt etg eaa get aat gac aea gee ata tat tac tgt
604 gac aag tee tee age aea gee tae atg gae gte ege aqe etg aea tet gag gat tet gca gtc tat tae tgt
605 gte aca tee aee age aet gee tae atg gag etc age age etg aca aat gag qae tet geg gtc tat tac tgt
609 gae aaa tec tet age aca gcc cac atg gag etc ctq age ctg aea tet gag gac tet gca gte tat tat tgt
611 gac aat gee aag aae ace ctg tae etg eaa atg age agt etg agg tet gag gae acg gcc atg tat tae tgt
612 gac aca tec tec age aea gee tac ntg cag etc age aqe etg aca tet gag gae tea gcg gtc tat tac tgt
100
603
604
605
609
611
612
gee aga aae qct ta
gea aga ate ecc att aet aeg get acg aac tgg tac tte gat gt
aca aga tet aet atg att acg aeg gte - tat get atg gae ta
qqa aga age c«a - - - - - " " get "tg gac ta
gca aga cag tat ggt aac tac aag gac -
aca aga gga ggg gte z —
- tae ttt gac ta
(03
604
605
£09
«11
612
t e t
t e e
LCC
t e c
t e e
t e c
qca
t e a
t e a
t e a
t e a
tea
tgg ggc eaa ggg aet ctg gtc act qte
tqq qgc gea ggg a
tgg qqt caa qg* a
tgg gqt eaa qqa a
tgg ggc caa gqe a
tgg ggc eaa ggc a
ec
ee
ce
cc
cc
acg
t e a
t e a
ac t
a c t
g t c
g t c
g t e
c t e
c 'c
a
a
a
a
a
t
c
c
a
• a
g t c
g t c
g t e
g t c
g t c
Figure 3 Nucleotide sequences of
the heavy chain variable regions of
early primary anti-MEP 17-31 IgM
mAb were determined. Identical
sequences were obtained for mAb
612, 613 and 614 as a result of
which only that of mAb 612 is
shown. The CDR regions are under-
lined. Numbering of codons is
according to Kabal er at.'^
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Distribution of epitope fine-specificities of IgM mAh
Given the diverse array of IgM paratope con figurations that
are induced we next analysed epitope fine-specificities for
each of these mAb. This was achieved by examining individ-
ual mAb cross-reactivities against the overlapping hexapep-
tide panel described in Fig. 2. The majority of the mAb. on
subjection to this kind of analysis, reacted with a limited set
of overlapping peptides that permitted easy interpretation.
Monoclonal antibodies 612, 613 and 614, however, reacted
with multiple hexapeptides suggestive of polyreactivity.
Table 2 summarizes the results for all the mAb along with
dissociation constant values for MEP-I. As is evident, the
distribution of IgM mAb specificities suggests that the MEP
17-31 presents at least two distinct determinants for pre-
immune B cell recognition (Table 2). Thus while mAb
603-605 and 611 display unique fine-specificities they never-
theless focus within a pentapeptide stretch. MEP 19-23.
Monoclonal antibodies 60S and 609 collectively define a
second distinct determinant within MEP residues 26-28.
Notably, however, the IgM response appears to be biased in
favour of the MEP 19-23 segment with four of the nine
obtained mAb being directed against it.
IgG class mAh lo MEP 17-31 are restricted in epitope
fine-specificity and phenotype diversity
It was intriguing that even as small an antigenic determinant
as the MEP 19-23 segment of MEP-1 could induce pre-
immune B cells with slg receptors that are diverse both in
genetic make-up and paratope structure (as presumed from
the variable Ig,^  CDR3). This was in tum reflected at the level
of antigen-antibody interactions where marked affinity differ-
ences were observed. We were therefore interested in deter-
mining the level of antibody heterogeneity in the mature IgG
response. For this a BALB/c mouse that had been immunized
with MEP-1 4 weeks earlier (day 28) was boosted with solu-
ble antigen and anti-MEP 17-31 IgG secreting hybridomas
derived from a fusion that was performed 3 days later. A total
of five clones could be stabilized, all of which secreted anti-
bodies which were found to map exclusively against the MEP
20-23 segment (data not shown but identical to Fig. 2b).
These were subsequently used to determine the sequence of
the IgH variable region.
Table 2 Binding properties of early primary anti-MEP 17-31
mAb
IgM
Monoclonal antibody
603
604
605
608
609
611
612-614
K^ (mol/L)
1.3 X 10-''
I.I X 10^
7.5 X 10-s
ND
2.5 X 10-"
1.5 X 10-»
2.8 X 10-«
Minimum binding domain
LDPA
DPAF
DPA
NST
NST
DPA
Poly re active
Dissociation constants were determined by the method of Frigiiet
et al.^^ and are the mean of two separate determinations. The mini-
mum binding domain and anchor residues were identified as
described in the text. ND, not determined.
As shown in Fig. 4 and Table 3 all five sequences showed
a remarkable degree of similarity utilizing the V^ J558,
D^ FL16.1 and J^ gene combination with near identical
Vj^-D^ and D^-J^ joinings and CDR3 regions. While there
were minor differences in nucleotide sequence, all represent-
ed transversional changes, suggesting that they may have
resulted from somatic mutations within germinal centres.'^
Thus, based on prior estimates of the probability of indepen-
dent identity at the VDJ junction, it is likely that the five IgG
mAb were obtained from B cells representing somatically
mutated variants derived from a common progenitor.'^ This
was further substantiated by obtaining the nucleotide
sequence of all five light chains. Again nearly idetitical
sequences (V^ from group V, and J^l) were obtained barring
minor differences that could also be accounted for by invok-
ing somatic mutations (Fig. 5). A sequence comparison of
IgM and IgG mAb revealed that our IgM mAb panel did not
contain Igj^  sequences that were homologous to heavy chain
variable regions of the IgG mAb.
Discussion
To date, generation and maturation of antibody responses
have been principally studied using a variety of haptens
as surrogate antigens. Such model systems have provided
valuable insights into the mechanics of B cell responses.
However, several unanswered questions remain, particularly
with respect to more "natural" antigens such as polypeptides.
Given the inherent confonmational flexibility and varied
micro-environments, due to localizLHl variations in amino acid
composition, even a relatively small peptide is expected to
provide a multiple array of determinants I'or B cell recogni-
tion. Thus, resolution of humoral responses against such anti-
gens is likely to involve a greater degree of complexity than
that against haptens. For example, immunization with
polypeptide immunogens is expected to activate pre-immune
B cells that are diverse not only in terms of clonality but also
epitope fine-specificities. This raises the intriguing question
of whether clonal selection of B cells directed against inde-
pendent specificities operates in an autonomous fashion or
whether it also includes interspecific competitive selection. In
this connection the underlying basis for the observations of
restricted immunodominanee among the epitope repertoire
presented by proteiti antigens continues to remain an enigma.
To probe some of these issues a designed, recombinant
polypeptide MEP-1 was used. Prior studies had established
that a segment representing residues 17-31 of the polypeptide
constituted an immunodominant region of this molecule,
accounting for at least 90% of the total primary antibody
response to MEP-1. The MEP 17-31 segment therefore
appeared to represent a good model detenninant tor study.
Immunization of mouse strains of a variety of H-2 haplo-
typcs with a single dose of MEP-1 induced an early primary
IgM response that was multispecific with respect to the MEP
17-31 segment. Dissection of the BALB/c IgM response into
individual mAb revealed the presence of at least two distinct
antigenic sub-segments. MEP 19-23 and MEP 26-28. within
MEP 17-31 in the context of MEP-1. Interestingly, subse-
quent maturation was exclusively restricted to the MEP
19-23 region with loss of all alternate specificities. The fact
that qualitatively similar results were obtained in mice of all
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623 cag qtg caa ctg cag gag tet ggg get gag ctg gtg agg cct ggg gtc tea gtg aag att tec tgc aag ggt tet ggc
624 cag gtg aag ctg cag gag tea ggg get gag etg gtg agg eet ggg gtc tea gtg aag att tec tge aag ggt tet ggc
626 cag gte aaa ctg cag gag tea ggg get gag etg gtg agg eet ggg gte tea gtg aag att tee tgc aag ggt tet gge
627 eag gtg aag etg cag gag tet ggg get gag etg gtg agg eet ggg gtc tea gtg aag att tec tge aag ggt tet gge
621 cag gtg eag etg cag gag tea ggg get gag etg gtg agg cca ggg gtc tea gtg aag att tee tgc sag ggt tet ggc
30 *0 50
£23 tae aca ttc act gat tat get atg cae tgg gtg agg cag agt cat gca aag agt tta gag tgg att gga ggt att aga
624 tae aca tte act gat ttt get atg eae tgg gtg aag cag agt cat tea aag agt eta gag tgg att gga ggt ate agg
62< tae aca ttc aet gat tat get atg cac tgg gtg aag eag agt cat gea aag agt eta gag tgg att gga ggt ate agg
627 tac aea ttc aet gat tat get ata eac tgg gtg aag eag agt eat gca aag agt eta gag tgg att gga ggt ttt agt
tac aea tte act gar, tat, get at.a r.ac tgg gtg aag eag agt eae gea aag agt eta gag tgg att gga gjt ttt aqt621
con 1
60 ^o
623 eet tae tat ggt gat gta agt tac aac cag aag ttc aag ggc aag gee aea atg act gta gae aaa tee tec age aea
624 aet tae aat ggt gae gte age tae aac eag aag tte aag ggc aag gcc aca atg aet gta gae aaa tec tee age aca
626 aet tac aat ggt gac gtc age tac aae eag aag tte aag ggc aag gee aea atg act gta gac aaa tec tec age aea
627 ttt tac tat get gat get ace tac aac eag aag tte aag ggc aag gee aca atg aet gta gac aaa tee tee age aea
628 ttt. tac tat ac.r gar qf:t Aac tat aan r.ag aag tte aag ggc aag gee aea atg aet gta gac aaa tec tee age aca
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€23 gee tat atg gaa ett gee aga ctg aea tet gag gat tet gee ate tat tae tgt gea aga tat tec tae ggt agt ttt
624 gee tat atg gaa ett gee aga etg aea tet gag gat tet gee ate tat tae tgt gea aga tat tae tae ggt agt ttt
626 gcc tat atg gaa ett gee aga etg aca tet gag gat tet gee ate tat tae tgt gea aga tat tee tae ggt agt ttt
627 gee tat atg gaa ett gee aga etg aca tet gag gat tet gee ate tat tae tgt gea aga tat tte tae ggt agt ttt
621 gee tat atg gaa ett gee aga etg aea tet gag gat tet gee ace tat tae tgt gea aga tflt ttC tftQ flflt flgt ttt
csn 3
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623 gae tae tgg gge caa ggc aec aet ete aea gte tee tea
624 gac tae tgg gge eaa gge aee aet etc aca gtc tee tea
626 gae tae tgg gge caa ggc ace act etc aca gtc tee tea
627 gac tae tgg gge caa ggc aee aet ete aca gtc tee tea
629 gac tflc; tgg gge eaa gge aee aet etc aca gtc tec tea
Figure 4 Nucleoiide sequence of immunoglobulin heavy chain variable regions of mature anti-MEP 17-31 IgG mAb. The CDR regions are
underlined. Numbering of codons is according to Kabat et al.^^
Table 3 Clona! diversity of mature anti-MEP 17-31 IgG mAb
Monoclonal antibody Antibody isotype Heavy chain CDR3 sequence (amino acid) of
623
624
626
627
628
2b
2b
1
2a
2a
J558
J558
J558
J558
J558
FL16.1
FL16.1
FL16.1
FL16.1
FLI6.1
2
2
2
2
2
YSYGSFDY
YYYGSFDY
YSYGSFDY
YFYGSFDY
YFYGSFDY
QQGQSYPRT
LQGQSYPRT
LQGQSYPRT
QQGQIYPRT
QQGQIYPRT
4.5 X
2.1 X
5.1 X
9.2 X I a-"*
1.8 X 10-'^
IgG heavy chain isotypes u-ere determined with the mouse monoclonal isotyping kit from Scrotec (Oxford. UK). Light chain isotypes were
determined by ELISA u.sing appropriate antibodies. Dissociation constants were e.stimated using the procedure of Friguet et al.^^ and anchor
residues determined as described in the text. Heavy chain V. D. J and CDR3 sequences are derived from Fig. 4.
four haplotypes suggests that MEP 19-23 dominance is inde-
pendenl ofthe genetic background ofthe mouse strain used.
The results described ahove clearly indicate that recogni-
tion by pre-immune B cells alone is insufficient to render an
antigenic segment immunodominant. Thus for example,
though the MEP 26-28 region does induce early primary IgM
antibodies, it becomes crypttc in the later stages of the
response. It is presently not clear as to why the early MEP
26-28 induced B cells are unable to continue in the response.
A priori, however, their elimination could result from either
competitive or non-competitive processes. We recently
reported that mutation of the proline residue at position 21
(a residue critical for the MEP 19-23 epitope) for glycine
completely abrogated the primary antibody response to MEP
19-23. with an overall 30-fold reduction in anti-MEP-1 titreJ
This would seem to imply that loss of anti-MEP 26-28 speci-
ficities is not a consequence of competitive suppression by
the anti-MEP 19-23 specific B cells, but rather they are
autonomously regulated.
The existence of yet another level of selection became
apparent when we examitied the clonal heterogeneity of B
cells participating in the early and late stages of the anti-MEP
19-23 response. The early IgM component was found to
derive from an oligocional population of B cells as evidenced
from the varied Ig,., V-D-J combinations obtained for the
individual mAb. Interestingly, the divergent heavy chain
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623 qaa a t t gtg ate acc cag t e t ega tee agt etq t e t gea tec e t t gga gae aea a t t ace
624 aec cag act cea tec agt ctg t e t gea tee e t t gga gae aca a t t acc
626 aac cag t e t eea tee agt etq t e t gea tee e t t gqa gae aea a t t aec
627 a t t qtg ete aee cag t e t cca tee agt etg t e t gea tee e t t gqa gae aca a t t acc
628 qac a t t gtg etc aca eag t e t cca tee agt ctg t e t gea tee e t t gqa qac aca a t t aee
623
624
626
627
62 S
623
624
626
627
628
623
624
626
627
628
ate aet tge cat gee agt eag aae
ate aet tge eat gee agt cag aae
ate aet tge cat gee agt eag aae
ate aet tge eat gee agt cag aae
ate aet tgc cut ace agt cita aac
30
att aat
att aat
att aat
att aat
at^t aat
gtt tgg tta age tgg tae eaa cag aaa eea
gtt tgg tta age tgg tac eag eag aaa eea
gtt tgg tta age tgg tae eag eag aaa eea
gtt tgg tta age tgg tae eag eag aaa eea
gtt tag tta ayt tag tac eag eag aaa eea
gga aat att eet aaa eta ttg ate
gga aat att eet aaa eta ttg ate
gga aat att eet aaa eta ttg ate
gga aat att eet aaa eta ttg ate
gga aat att eet aaa eta ttg ate
agg ttt agt gge agt gga tet gga
agg ttt agt gge agt gga tet gga
agg ttt agt gge agt gga tet gga
agg ttt aqt gge agt gga tet gga
agg ttt agt gge agt gga tet gga
SO
tat aag
ttt aag
ttt aag
tat aag
tat Aan
get tee aae ttg
get tee aae ttg
get tee aae ttg
tet tee aae ttg
act tee. aar rta
eae aea ggt gte eea tea
eae aea gge qte cca tea
eac aea gge gte eea tea
eae aea gge gte eea tea
TAr Ara ggc gte cca tea
•JO
aea ggt
aea ggt
aea ggt
aea ggt
aea ggt
CD* II
ttc aca tta aec
ttc aca tta aec
ttc aca tta ace
tte aea tta ace
tte aea tta ace
•0
ate age age etg eag eet
aCc age age etg cag cct
ate age age ctg eag eet
ate age agt ttg cag eet
ate age age ctg cag cct
Figure 5 Nucleotide sequences of
the light chains of each of the five
IgG mAb obtained against MEP-i.
The CDR regions are underlined.
Numbering of codons is according to
Kabat r/d/.'8
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623 qaa qac att qce aet tac tae tgt caa caq qqt caa aqt tat cct eqq acg tte ggt qqa
624 gaa qac att gcc act tac tac tgt eta cag ggt caa aqt tat cct eqq acq ttc qqt qqa
626 qaa qac att qce act tac tae tgt eta caq qqt eaa aqt tat eet eqq aeq ttc qqt qqa
627 gaa gac att qce act tae tae tgt caa caq ggt caa att tat cct eqq acg ttc ggt gga
628 qaa gac att gcc act tac tae tgt caa cag gqt caa att tat cct egg acg ttc ggt gga
com HI
623 gqe acc aag etq qaa ate aaa
624 gqe acc aaq ctg gaa ate aaa
626 ggc acc aag etq gaa ate aaa
627 gqe acc agg etg gaa ate aaa
628 gqe acc aaq ctg gea ate aaa
CDR3 sequences obtained for these mAb were also indicative
of phenotypic diversity of antibody paratopes; perhaps a
reflection of some degree of confomiational tlexibility of
MEP 19-23 segment in the context of MEP-l. In stark
contrast, all five late stage IgG mAb obtained were found to
utilize identical Vf/, D^ and J,i gene segments with near iden-
tical V-D und D-J joinings. Furthermore, this identity also
extended to the Ig light chains utilized by these mAb. These
results thus provide evidence for an additional level of selec-
tion which is strictly intraspecific and seeks to restrict
heterogeneity of the epitope-specific responder population
during progression of the humoral response.
It is possible, though not certain, that clonotypes producing
the five IgG mAb were derived from a common progenitor
where minor differences in nucleotide sequence are a result
of somatic mutations. This presumption is supported by the
following observations: (i) prior estimates of the probability
of independent identity at the VDJ junction'^ strongly suggest
that these five IgG mAb are unlikely to have been a product
of independently derived clonotypes; (ii) the consistent
absence of A' region additions at the V^-D,^ and D,,-J^ junc-
tions is also indicative of clonal relatedness, though the origin
of these cells needs to be ascertained; and (iii) finally, utiliza-
tion of common light chain by all of these live mAb further
argues against independent identity. Nevertheless, we caution
that these are only inferential arguments and definitive
evidence is presently lacking. If indeed these five IgG mAb-
producing B cells share a common precursor then the
diversity of antibody isotypes obtained is also intriguing. A
plausible explanation for this could be that these five clones
represent divergence from a common IgM producing progen-
itor with subsequent isotype switch occurring in an auto-
nomous fashion.
To summarize, studies described here suggest that
immunogenicity of a B cell determinant, at least at a func-
tional level, i.s not solely dictated by its accessibility for B
cell recognition. Rather, following the initial recognition
event, immunological parameters come into play which
restrict the antibody fine-specificities during subsequent mat-
uration. Qualitatively, our results are consistent with prior
observations of Newman et al.^ In their studies on evolution
of murine antibody responses to hen egg-white lysozynie they
observed that the early response is not characterized by any
particular specificity pattern but rather appeared to represent
a random sampling from a continuum of antigenic determi-
nants. In contrast, the late response was functionally grouped
into di.screte antigenic regions.** In addition, our data also
provide evidence for a reduction in clonal heterogeneity of
epitope-specific antibodies as the response progresses. What
determines specificity selection during progression of a
humoral response remains a question of considerable interest.
Our own earlier results seem to suggest that the ability of
individual antigen-activated B cells to recruit T cell help
defines at least one of the discriminatory criteria.^^ Whether
sitnilar factors also regulate clonal heterogeneity of determi-
nant-specific responses reniatns to be ascertained.
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